ArticleAIDS research and therapy2022

Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial.

Nolwenn Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.